🟢 Tiziana Life Sciences is trading 7.35% up today after BTIG initiated coverage with a Buy rating

Tiziana Life Sciences is trading at $1.00, up +7.35%, after BTIG initiated coverage on September 3, 2026, with a Buy rating and a $7.00 price target.

• The target represents substantial implied upside from the September 2 close of $0.93, supporting renewed speculative interest.
• Broader biotechnology strength, including the sector’s 2.75% gain, is providing additional support, but the analyst initiation is the clearest catalyst.